Last updated on April 2005

Opportunity to participate: New Psoriasis Study Being Conducted


Brief description of study

Opportunity to participate: New Psoriasis Study Being Conducted

Detailed Study Description

Skin Conditions: Must have moderate to severe plaque-type psoriasis.

Name of Medication Being Tested: Etanercept (Enbrel ®)

Criteria Needed to be Entered into Study:

  • Children 4 to 17 years of age
  • Must have psoriasis for minimum of 6 months
  • Minimum 10% of total body surface area of psoriasis
  • Must have either one of the following medication history:
    • Have had or currently being treated with medication such as PUVA, UVB, UVA, Methotrexate, Cyclosporine, Retinoids
    • Poorly controlled with certain types of topical psoriasis therapy

Reasons Why You May Not Qualify: Have used Enbrel in the past

Study Specifics:

  • 52 to 57 week study with 16 visits
  • Study enrollment begins August 2004

If you are interested in receiving more information about this research study or are interested in being involved in the research,

Clinical Study Identifier: TX134114

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Clinical Partners, LLC

Clinical Partners, LLC
Johnston, RI USA
  Connect »